# US 2008/0306580 A1 · Blood acess apparatus and method

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0306580 A1
- Document ID: US20080306580A1
- Status: Published application
- Kind: A1
- Application number: 12/025,350
- Filed: 2008-02-04
- Published: 2008-12-11
- Earliest claimed: 2007-02-05
- Assignees: Boston Scientific Scimed, Inc.
- Inventors: Mark L. Jenson; William J. Drasler; Jason P. Hill; Jaydeep Kokate; David J. Sogard; Pat Haverkost
- Web page: https://patentgrep.com/patent/US20080306580A1

## CPC

- A61M 1/3655: {Arterio-venous shunts or fistulae}
- A61F 2/07: Stent-grafts
- A61F 2/82: Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07)
- A61F 2/90: characterised by a net-like or mesh-like structure
- A61F 2002/072: {Encapsulated stents, e.g. wire or whole stent embedded in lining}
- A61F 2002/075: {the stent being loosely attached to the graft material, e.g. by stitching}
- Y10T 29/49826: Assembling or joining
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

A blood access for dialysis includes a radially distensible support structure having an open lattice structure defining a support wall having interstitial open areas and defining exterior and luminal wall surfaces; a first porous polymeric portion having a plurality of pores, the first porous polymeric portion being securably disposed over at least a portion of the exterior wall portion of the support structure; a second porous polymeric portion having a plurality of pores, the second porous polymeric portion being securably disposed over at least a portion of the luminal portion of the support structure; and a biodegradable and/or bioabsorbable material disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion.

## Claims

### Claim 1

A blood access device comprising:
a radially distensible support structure having an open lattice structure defining a support wall having interstitial open areas and defining exterior and luminal wall surfaces; and
a first porous polymeric portion having a plurality of pores, the first porous polymeric portion being securably disposed over at least a portion of the exterior wall portion of the support structure.

### Claim 2 (depends on 1)

The blood access device of claim 1, further comprising:
a second porous polymeric portion having a plurality of pores, the second porous polymeric portion being securably disposed over at least a portion of the luminal portion of the support structure.

### Claim 3 (depends on 1)

The blood access device of claim 1, wherein the first porous polymeric portion and the second porous polymeric portion are a unitary porous polymeric portion.

### Claim 4 (depends on 2)

The blood access device of claim 2, wherein the first and/or the second polymeric portions encapsulate the support structure.

### Claim 5 (depends on 2)

The blood access device of claim 2, wherein the first polymeric portion and/or the second polymeric portion are disposed within interstitial open areas of the support structure.

### Claim 6 (depends on 2)

The blood access device of claim 2, further comprising:
a biodegradable and/or bioabsorbable material disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion.

### Claim 7 (depends on 2)

The blood access device of claim 2, further comprising a porous layer or coating of expanded polytetrafluoroethylene disposed over a luminal surface of the second polymeric portion.

### Claim 8 (depends on 1)

The blood access device of claim 1, wherein the support structure is a self-expanding support structure.

### Claim 9 (depends on 1)

The blood access device of claim 1, wherein the support structure is selected from the group consisting of a filament-based structure, an open slotted structure, a mesh or fenestrated structure, and combinations thereof.

### Claim 10 (depends on 9)

The blood access device of claim 9, wherein the filament based structure is selected from the group consisting of a braided structure, a knitted structure, a wound structure, a helical structure, a zig-zag structure, and combinations thereof.

### Claim 11 (depends on 1)

The blood access device of claim 1, wherein the support structure comprises nitinol, stainless steel, cobalt-based alloy such as Elgiloy®, platinum, gold, titanium, tantalum, niobium, polymeric materials and combinations thereof.

### Claim 12 (depends on 1)

The blood access device of claim 1, wherein the support structure comprises nitinol.

### Claim 13 (depends on 1)

The blood access device of claim 1, wherein the support structure comprises vapor deposited nitinol.

### Claim 14 (depends on 1)

The blood access device of claim 1, wherein the first polymeric portion comprises an elastomeric material.

### Claim 15 (depends on 2)

The blood access device of claim 2, wherein the second polymeric portion comprises an elastomeric material.

### Claim 16 (depends on 2)

The blood access device of claim 2, wherein the first and second polymeric portions comprise an elastomeric material.

### Claim 17 (depends on 16)

The blood access device of claim 16, wherein the elastomeric material of the first polymeric portion is the same as the elastomeric material of the second polymeric portion.

### Claim 18 (depends on 16)

The blood access device of claim 16, wherein the elastomeric material of the first polymeric portion is different from the elastomeric material of the second polymeric portion.

### Claim 19 (depends on 14)

The blood access device of claim 14, wherein the elastomeric material is selected from the group consisting of styrene isobutylene styrenes, natural rubbers, silicones, polyurethanes, and combinations, co-polymers, block polymers and random polymers thereof.

### Claim 20 (depends on 14)

The blood access device of claim 14, wherein the elastomeric material comprises styrene isobutylene styrene polymer and co-polymers, block polymers and random polymers thereof.

### Claim 21 (depends on 2)

The blood access device of claim 2, wherein the first and second polymeric portions comprise textile portions, non-textile portions, and combinations thereof.

### Claim 22 (depends on 2)

The blood access device of claim 2, wherein the first and second polymeric portions comprise filament spun portions, wherein the filaments comprise an elastomeric material.

### Claim 23 (depends on 22)

The blood access device of claim 22, wherein the elastomeric material comprises styrene isobutylene styrene polymer and co-polymers, block polymers and random polymers thereof.

### Claim 24 (depends on 2)

The blood access device of claim 2, further comprising a therapeutic agent disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion.

### Claim 25 (depends on 2)

The blood access device of claim 2, wherein the pores of the first polymeric portion and/or the second polymeric portion have a pore size from about 40 microns to about 150 microns.

### Claim 26 (depends on 2)

The blood access device of claim 2, wherein the wall of the support structure has a thickness from about 0.0005 inches (0.01 mm) to about 0.008 inches (0.2 mm).

### Claim 27 (depends on 2)

The blood access device of claim 2, wherein the wall of the support structure has a thickness from about 0.001 inches (0.03 nm) to about 0.004 inches (0.1 mm).

### Claim 28 (depends on 2)

The blood access device of claim 2, wherein the first and second polymeric portions have an individual or combined thickness from about 0.002 inches (50 microns) to about 0.06 inches (1.5 mm).

### Claim 29

A blood access for dialysis comprising:
a radially distensible support structure having an open lattice structure defining a support wall having interstitial open areas and defining exterior and luminal wall surfaces;
a first porous polymeric portion having a plurality of pores, the first porous polymeric portion being securably disposed over at least a portion of the exterior wall portion of the support structure;
a second porous polymeric portion having a plurality of pores, the second porous polymeric portion being securably disposed over at least a portion of the luminal portion of the support structure; and
a biodegradable and/or bioabsorbable material disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion.

### Claim 30 (depends on 29)

The device of claim 29, wherein the support structure comprises nitinol.

### Claim 31 (depends on 29)

The device of claim 29, wherein the first and the second polymeric portions comprises elastomeric styrene-isobutylene-styrene.

### Claim 32

A system for providing blood access for dialysis, comprising:
a radially distensible support structure having an open lattice structure defining a support wall having interstitial open areas and defining exterior and luminal wall surfaces;
a first porous polymeric portion having a plurality of pores, the first porous polymeric portion being securably disposed over at least a portion of the exterior wall portion of the support structure;
a second porous polymeric portion having a plurality of pores, the second porous polymeric portion being securably disposed over at least a portion of the luminal portion of the support structure;
a biodegradable and/or bioabsorbable material disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion; and
a delivery device for transluminally delivering the blood access within a bodily lumen.

### Claim 33

A method of reducing arteriovenous fistula maturation comprising:
cutting or severing a vein into a first and a second portion, each portion having open ends;
ligating the open end of the first vein portion;
inserting a blood access device through the open end of the second vein portion; and
anastomosing the open end of the second vein to an artery.

### Claim 34 (depends on 33)

The method of claim 33, wherein the blood access device comprises:
a radially distensible support structure having an open lattice structure defining a support wall having interstitial open areas and defining exterior and luminal wall surfaces;
a first porous polymeric portion having a plurality of pores, the first porous polymeric portion being securably disposed over at least a portion of the exterior wall portion of the support structure;
a second porous polymeric portion having a plurality of pores, the second porous polymeric portion being securably disposed over at least a portion of the luminal portion of the support structure; and
a biodegradable and/or bioabsorbable material disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion.

### Claim 35 (depends on 33)

The method of claim 33, wherein the blood access device is useable prior to complete maturation of the arteriovenous fistula.

### Claim 36 (depends on 35)

The method of claim 35, wherein the blood access device is useable within about one week after being implanted.

### Claim 37

A method of creating an arteriovenous fistula comprising:
cutting or severing a vein into a first and a second portion, each portion having open ends;
ligating the open end of the first vein portion;
inserting a blood access device through the open end of the second vein portion; and
anastomosing the open end of the second vein to an artery.

### Claim 38 (depends on 37)

The method of claim 37, wherein the blood access device comprises:
a radially distensible support structure having an open lattice structure defining a support wall having interstitial open areas and defining exterior and luminal wall surfaces;
a first porous polymeric portion having a plurality of pores, the first porous polymeric portion being securably disposed over at least a portion of the exterior wall portion of the support structure;
a second porous polymeric portion having a plurality of pores, the second porous polymeric portion being securably disposed over at least a portion of the luminal portion of the support structure; and
a biodegradable and/or bioabsorbable material disposed within the pores of the first polymeric portion and/or pores of the second polymeric portion.

### Claim 39 (depends on 38)

The method of claim 38, wherein the blood access device is useable prior to complete maturation of the arteriovenous fistula.

### Claim 40 (depends on 39)

The method of claim 39, wherein the blood access device is useable within about one week after being implanted.

### Claim 41 (depends on 37)

The method of claim 37, wherein the support structure tends to limit the expansion or an internal diameter of the vein proximal to the site of implantation of the blood access device.

### Claim 42 (depends on 37)

The method of claim 37, wherein the blood access device encompasses a minor portion of the second vein portion.

### Claim 43 (depends on 37)

The method of claim 37, wherein the blood access device encompasses a major portion of the second vein portion.

### Claim 44

A method for making a blood access device for use in dialysis, comprising:
providing a porous polymeric substrate;
disposing a radially distensible support structure over the porous polymeric structure,
providing another porous polymeric substrate over the support structure; and
securing the substrates to one and the other anchor to the support structure.

### Claim 45 (depends on 44)

The method of claim 44, where the steps of providing the porous polymeric substrates further comprise providing an elastomeric material.

### Claim 46 (depends on 45)

The method of claim 45, further comprising the step of spinning or spraying filaments of the elastomeric material.

### Claim 47 (depends on 46)

The method of claim 46, wherein the elastomeric material styrene isobutylene styrene polymer and co-polymers, block polymers and random polymers thereof.
